In Brief: Medco Research ViaScint
Executive Summary
Medco Research ViaScint: Nuclear imaging agent is "not approvable" on July 25. Medco Research said that ViaScint, irrespective of its review status, will be partnered out or rights will be returned to Nordion with Medco Research retaining a carried interest. The ViaScint NDA was submitted March 28, 1996...